» Articles » PMID: 31799184

A Five-microRNA Signature As Prognostic Biomarker in Colorectal Cancer by Bioinformatics Analysis

Overview
Journal Front Oncol
Specialty Oncology
Date 2019 Dec 5
PMID 31799184
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Mounting evidence has demonstrated that a lot of miRNAs are overexpressed or downregulated in colorectal cancer (CRC) tissues and play a crucial role in tumorigenesis, invasion, and migration. The aim of our study was to screen new biomarkers related to CRC prognosis by bioinformatics analysis. By using the R language edgeR package for the differential analysis and standardization of miRNA expression profiles from The Cancer Genome Atlas (TCGA), 502 differentially expressed miRNAs (343 up-regulated, 159 down-regulated) were screened based on the cut-off criteria of < 0.05 and |log2FC|>1, then all the patients (421) with differentially expressed miRNAs and complete survival time, status were then randomly divided into train group (212) and the test group (209). Eight miRNAs with < 0.005 were revealed in univariate cox regression analysis of train group, then stepwise multivariate cox regression was applied for constituting a five-miRNA (hsa-miR-5091, hsa-miR-10b-3p, hsa-miR-9-5p, hsa-miR-187-3p, hsa-miR-32-5p) signature prognostic biomarkers with obviously different overall survival. Test group and entire group shown the same results utilizing the same prescient miRNA signature. The area under curve (AUC) of receiver operating characteristic (ROC) curve for predicting 5 years survival in train group, test group, and whole cohort were 0.79, 0.679, and 0.744, respectively, which demonstrated better predictive power of prognostic model. Furthermore, Univariate cox regression and multivariate cox regression considering other clinical factors displayed that the five-miRNA signature could serve as an independent prognostic factor. In order to predict the potential biological functions of five-miRNA signature, target genes of these five miRNAs were analyzed by Kyoto Encyclopedia of Genes and Genomes (KEGG) signaling pathway and Gene Ontology (GO) enrichment analysis. The top 10 hub genes (ESR1, ADCY9, MEF2C, NRXN1, ADCY5, FGF2, KITLG, GATA1, GRIA1, KAT2B) of target genes in protein protein interaction (PPI) network were screened by string database and Cytoscape 3.6.1 (plug-in cytoHubba). In addition, 19 of target genes were associated with survival prognosis. Taken together, the current study showed the model of five-miRNA signature could efficiently function as a novel and independent prognosis biomarker and therapeutic target for CRC patients.

Citing Articles

Identification of hub biomarkers and immune cell infiltrations participating in the pathogenesis of endometriosis.

Li K, Wang J, Liu X, Dang Y, Wang K, Li M Sci Rep. 2025; 15(1):2802.

PMID: 39843899 PMC: 11754470. DOI: 10.1038/s41598-025-86164-y.


Ferroptosis-related genes participate in the microglia-induced neuroinflammation of spinal cord injury via NF-κB signaling: evidence from integrated single-cell and spatial transcriptomic analysis.

Wang S, Yang L, Wu Z, Li C, Wang S, Xiao Z J Transl Med. 2025; 23(1):43.

PMID: 39799354 PMC: 11725224. DOI: 10.1186/s12967-025-06095-0.


Circulating miRNA Signature Predicts Cancer Incidence in Lynch Syndrome-A Pilot Study.

Sievanen T, Jokela T, Hyvarinen M, Korhonen T, Pylvanainen K, Mecklin J Cancer Prev Res (Phila). 2024; 17(6):243-254.

PMID: 38551987 PMC: 11148538. DOI: 10.1158/1940-6207.CAPR-23-0368.


MicroRNA-183 cluster: a promising biomarker and therapeutic target in gastrointestinal malignancies.

Zheng Y, Sukocheva O, Tse E, Neganova M, Aleksandrova Y, Zhao R Am J Cancer Res. 2024; 13(12):6147-6175.

PMID: 38187051 PMC: 10767355.


An Updated Review on Molecular Biomarkers in Diagnosis and Therapy of Colorectal Cancer.

Nagainallur Ravichandran S, Kumar M, Das A, Banerjee A, Veronica S, Sun-Zhang A Curr Cancer Drug Targets. 2023; 24(6):595-611.

PMID: 38031267 DOI: 10.2174/0115680096270555231113074003.


References
1.
Adam R, De Gramont A, Figueras J, Kokudo N, Kunstlinger F, Loyer E . Managing synchronous liver metastases from colorectal cancer: a multidisciplinary international consensus. Cancer Treat Rev. 2015; 41(9):729-41. DOI: 10.1016/j.ctrv.2015.06.006. View

2.
Gires O . Lessons from common markers of tumor-initiating cells in solid cancers. Cell Mol Life Sci. 2011; 68(24):4009-22. PMC: 11114982. DOI: 10.1007/s00018-011-0772-9. View

3.
Fu X, Liu M, Qu S, Ma J, Zhang Y, Shi T . Exosomal microRNA-32-5p induces multidrug resistance in hepatocellular carcinoma via the PI3K/Akt pathway. J Exp Clin Cancer Res. 2018; 37(1):52. PMC: 5846230. DOI: 10.1186/s13046-018-0677-7. View

4.
Yu G, Wang L, Han Y, He Q . clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012; 16(5):284-7. PMC: 3339379. DOI: 10.1089/omi.2011.0118. View

5.
Masuda T, Hayashi N, Kuroda Y, Ito S, Eguchi H, Mimori K . MicroRNAs as Biomarkers in Colorectal Cancer. Cancers (Basel). 2017; 9(9). PMC: 5615339. DOI: 10.3390/cancers9090124. View